< Back to previous page
Researcher
Chantal Mathieu
- Disciplines:Endocrinology and metabolic diseases
Affiliations
- Clinical and Experimental Endocrinology (Division)
Member
From1 Oct 1999 → Today
Projects
61 - 70 of 75
- How does 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) act on immune cells during autoimmunity?From1 Dec 2010 → 30 Sep 2013Funding: BOF - Doctoral projects
- Acromegaly in Belgium: a multicentre clinical outcome studyFrom1 Oct 2010 → 1 Sep 2014Funding: Own budget, for example: patrimony, inscription fees, gifts
- The vitamin D system in autoimmune diabetes: unraveling the basis for protection.From1 Oct 2010 → 30 Sep 2016Funding: FWO fellowships
- FACS Cell sorter (FACSAriaII), central to the establishment of a K.U.Leuven FACS core Facility.From22 Jul 2010 → 21 Jan 2017Funding: Hercules - Small and Medium size research infrastructure
- Impact of uremic retention solutes on vitamin D and bone metabolism.From1 Jan 2010 → 31 Dec 2013Funding: FWO research project (including WEAVE projects)
- BetaCellYherapy.From1 Jan 2010 → 30 Jun 2015Funding: General Activities (Annex IV)
- Harnessing the vitamin D system for the prevention and treatment of type 1 diabetes.From1 Jan 2010 → 31 Dec 2013Funding: FWO research project (including WEAVE projects)
- Dynamic interaction between beta cells, antigens and immune system cells in type 1 diabetes.From1 Oct 2009 → 10 Mar 2016Funding: FWO fellowships
- NOVEL IMMUNOTHERAPIES IN TYPE 1 DIABETES: EXPLORING ANTIGEN-SPECIFIC AND NON-SPECIFIC APPROACHESFrom1 Oct 2009 → 16 Sep 2013Funding: Own budget, for example: patrimony, inscription fees, gifts
- To unravel - and interfere with - signal transduction cascades in immune-mediated B-cell death: How to make stronger B-cells?From1 Sep 2009 → 30 Jun 2010Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 708
- The Health Economics of Automated Insulin Delivery Systems and the Potential Use of Time in Range in Diabetes Modeling: A Narrative Review(2024)
Authors: Chantal Mathieu, Pieter Gillard
Pages: 66 - 75 - CD4+ T cells from individuals with type 1 diabetes respond to a novel class of deamidated peptides formed in pancreatic islets.(2024)
Authors: Rita Derua, Chantal Mathieu, Lut Overbergh
Pages: db230588 - The double burden: Navigating type 1 diabetes and obesity(2024)
Authors: Nele Steenackers, Chantal Mathieu, Bart Van Der Schueren
- Type 1 diabetes mellitus: a brave new world(2024)
Authors: Chantal Mathieu
Pages: 71 - 72 - Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes(2024)
Authors: Kristina Casteels, Chantal Mathieu
- A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab(2024)
Authors: Chantal Mathieu
- Hypoglycaemia after Initiation of CFTR Modulator Therapy in a Cystic Fibrosis Patient without Diabetes(2023)
Authors: Lieven Dupont, Natalie Lorent, Pieter Gillard, Bart Van Der Schueren, Ann Mertens, Chantal Mathieu, Roman Vangoitsenhoven
- Neutrophils: a driving force in type 1 diabetes?(2023)
Authors: Samal Bissenova, Chantal Mathieu, Conny Gysemans
- Footprint of pancreas infiltrating and circulating immune cells throughout type 1 diabetes development(2023)
Authors: Gabriele Sassi, Chantal Mathieu, Conny Gysemans
- MULTI-OMICS TECHNOLOGIES TO IDENTIFY BIOMARKERS FOR THERAPY PREDICTION AND RESPONSE IN TYPE 1 DIABETES(2023)
Authors: Gabriele Sassi, Chantal Mathieu, Conny Gysemans
Patents
1 - 6 of 6
- Biomarkers for diabetes therapy (Inventor)
- Biomarkers for diabetes therapy (Inventor)
- Improved methods for pancreatic islet transplantation (Inventor)
- Citrullinated peptides for diagnosis or treatment of diabetes (Inventor)
- Improved methods for pancreatic islet transplantation (Inventor)
- RESISTANCE TO OXIDATIVE STRESS (Inventor)